Ultima-Sermorelin: Compound Profile
Sermorelin acetate is a synthetic peptide fragment consisting of the first 29 amino acids of naturally occurring growth hormone releasing hormone (GHRH). This bioactive peptide represents the shortest functional sequence capable of binding to and activating GHRH receptors in preclinical research models. Ultima-Sermorelin 5mg from Ultima Peptides provides researchers with a precisely manufactured peptide for in-vitro laboratory investigations examining pituitary hormone regulation, receptor binding kinetics, and cellular signalling mechanisms. The compound’s structural similarity to endogenous GHRH makes it particularly valuable for comparative studies investigating peptide-receptor interactions and downstream signalling cascades. Research applications at Stroid UK Shop encompass both basic peptide biochemistry and advanced endocrine system modelling in controlled laboratory environments.
Laboratory Research Applications
Scientific investigations with sermorelin acetate typically examine its binding affinity to GHRH receptors, dose-response relationships in cellular assays, and signal transduction pathway activation. Researchers analyse the peptide’s ability to stimulate adenylyl cyclase activity and subsequent cAMP elevation in isolated pituitary cell cultures. Additional studies investigate the compound’s pharmacokinetic properties, including plasma stability, enzymatic degradation patterns, and receptor binding kinetics compared to full-length GHRH sequences. The peptide serves as a valuable research tool for studying pituitary function, examining growth hormone axis regulation, and investigating potential therapeutic applications in growth hormone deficiency models. Laboratory protocols often incorporate sermorelin acetate into comparative studies with other peptide research compounds to establish relative potency and selectivity profiles. Researchers investigating metabolic signalling frequently examine this compound alongside selective androgen receptor modulators to understand complex hormonal interactions. Many laboratories studying endocrine function utilise sermorelin acetate in conjunction with other research peptides to comprehensively evaluate hormone regulation mechanisms.
Technical Specifications
| Parameter | Specification |
|---|---|
| Peptide Sequence | GHRH(1-29) |
| Molecular Weight | 3357.88 g/mol |
| CAS Number | 86168-78-7 |
| Appearance | Lyophilised white powder |
| Purity | ≥98% (HPLC) |
| Storage Temperature | -20°C (lyophilised) |
| Solubility | Water, saline solutions |
Laboratory Compliance Statement
Ultima-Sermorelin 5mg is manufactured exclusively for in-vitro research applications and laboratory studies. This peptide compound is not intended for human consumption, clinical use, or therapeutic applications. Researchers must ensure appropriate laboratory safety protocols, proper storage conditions, and compliance with institutional research guidelines when conducting studies with this material. The product is designed specifically for qualified research institutions and experienced laboratory personnel investigating peptide biochemistry, endocrine signalling pathways, and hormone-receptor interactions in controlled experimental settings.
